Department of Medical and Surgical Specialities, "Transilvania" University of Brasov, Brasov, Romania.
Department of Pharmacy, University of Oradea, Oradea, Romania.
Eur J Pharm Sci. 2019 Nov 1;139:105067. doi: 10.1016/j.ejps.2019.105067. Epub 2019 Sep 6.
The purpose of this study is to evaluate the efficacy of intra-vesical instillations with hyaluronic acid (HA) in relieving lower urinary tract irritation symptoms in patients with urinary tract infections (UTIs) and bladder pain syndrome/interstitial cystitis (BPS/IC). This research, conducted in Romania, includes 30 patients with UTIs (Group I) and 24 with BPS/IC (Group II) as defined by European Association of Urology (EAU) Diagnostic Criteria. Data were collected prospectively, using pre- and post-treatment questionnaires for pelvic pain with a symptom scale for urination and frequency as well as visual analog scale (VAS) pain quizzes. At follow-up visits, at an average of 20 months, a significant improvement in urinary bladder pain, day-time urinary frequency and quality of life was observed in Group I patients. Group II patients experienced significant improvement in urinary bladder pain, urgency, nocturia and quality of life at the 15-month follow-up visit. Eighteen patients (75%) showed a complete response to intravesical HA instillations and required no further treatment. Our study demonstrates that intravesical HA instillations may be considered as an important treatment component, with long term positive effects in therapeutic strategy for optimal results in uncomplicated recurrent UTIs and BPS/IC, with good compliance and minimal side effects.
本研究旨在评估膀胱内注射透明质酸(HA)在缓解尿路感染(UTI)和膀胱疼痛综合征/间质性膀胱炎(BPS/IC)患者下尿路刺激症状方面的疗效。这项在罗马尼亚进行的研究纳入了 30 名符合欧洲泌尿外科学会(EAU)诊断标准的 UTI 患者(I 组)和 24 名 BPS/IC 患者(II 组)。前瞻性收集数据,使用治疗前后盆腔疼痛问卷,包括排尿和频率症状量表以及视觉模拟量表(VAS)疼痛问卷。在平均 20 个月的随访中,I 组患者的膀胱疼痛、白天尿频和生活质量显著改善。在 15 个月的随访中,II 组患者的膀胱疼痛、尿急、夜尿和生活质量也显著改善。18 名患者(75%)对膀胱内 HA 灌注有完全反应,无需进一步治疗。我们的研究表明,膀胱内 HA 灌注可作为一种重要的治疗手段,在治疗单纯复发性 UTI 和 BPS/IC 方面具有长期的积极效果,患者依从性好,副作用小。